Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Effect of glucomannan on obese patients: a clinical study.

Walsh DE, Yaghoubian V, Behforooz A.

Int J Obes. 1984;8(4):289-93.

PMID:
6096282
2.

Effect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial.

Salas-Salvadó J, Farrés X, Luque X, Narejos S, Borrell M, Basora J, Anguera A, Torres F, Bulló M, Balanza R; Fiber in Obesity-Study Group.

Br J Nutr. 2008 Jun;99(6):1380-7. Epub 2007 Nov 22.

PMID:
18031592
3.

Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men.

Arvill A, Bodin L.

Am J Clin Nutr. 1995 Mar;61(3):585-9.

PMID:
7872224
4.
5.

A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans.

Gallaher DD, Gallaher CM, Mahrt GJ, Carr TP, Hollingshead CH, Hesslink R Jr, Wise J.

J Am Coll Nutr. 2002 Oct;21(5):428-33.

PMID:
12356785
6.

Effects of a carbohydrate-restricted diet with and without supplemental soluble fiber on plasma low-density lipoprotein cholesterol and other clinical markers of cardiovascular risk.

Wood RJ, Fernandez ML, Sharman MJ, Silvestre R, Greene CM, Zern TL, Shrestha S, Judelson DA, Gomez AL, Kraemer WJ, Volek JS.

Metabolism. 2007 Jan;56(1):58-67.

PMID:
17161227
7.

Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.

Vuksan V, Sievenpiper JL, Owen R, Swilley JA, Spadafora P, Jenkins DJ, Vidgen E, Brighenti F, Josse RG, Leiter LA, Xu Z, Novokmet R.

Diabetes Care. 2000 Jan;23(1):9-14.

8.

Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.

Vuksan V, Jenkins DJ, Spadafora P, Sievenpiper JL, Owen R, Vidgen E, Brighenti F, Josse R, Leiter LA, Bruce-Thompson C.

Diabetes Care. 1999 Jun;22(6):913-9.

9.

[Chronic use of glucomannan in the dietary treatment of severe obesity].

Vita PM, Restelli A, Caspani P, Klinger R.

Minerva Med. 1992 Mar;83(3):135-9. Italian.

PMID:
1313163
10.

Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children.

Martino F, Martino E, Morrone F, Carnevali E, Forcone R, Niglio T.

Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):174-80.

PMID:
15955465
11.

Whole-grain ready-to-eat oat cereal, as part of a dietary program for weight loss, reduces low-density lipoprotein cholesterol in adults with overweight and obesity more than a dietary program including low-fiber control foods.

Maki KC, Beiseigel JM, Jonnalagadda SS, Gugger CK, Reeves MS, Farmer MV, Kaden VN, Rains TM.

J Am Diet Assoc. 2010 Feb;110(2):205-14. doi: 10.1016/j.jada.2009.10.037.

PMID:
20102847
12.

Glucomannan and obesity: a critical review.

Keithley J, Swanson B.

Altern Ther Health Med. 2005 Nov-Dec;11(6):30-4. Review.

PMID:
16320857
13.

Could dyslipidemic children benefit from glucomannan intake?

Guardamagna O, Abello F, Cagliero P, Visioli F.

Nutrition. 2013 Jul-Aug;29(7-8):1060-5. doi: 10.1016/j.nut.2013.02.010.

PMID:
23759268
14.

[The use of highly purified glucomannan-based fibers in childhood obesity].

Livieri C, Novazi F, Lorini R.

Pediatr Med Chir. 1992 Mar-Apr;14(2):195-8. Italian.

PMID:
1324483
15.

The benefits of early intervention in obese diabetic patients with FBCx: a new dietary fibre.

Grunberger G, Jen KL, Artiss JD.

Diabetes Metab Res Rev. 2007 Jan;23(1):56-62.

PMID:
17013969
16.
17.

Fiber (glucomannan) is beneficial in the treatment of childhood constipation.

Loening-Baucke V, Miele E, Staiano A.

Pediatrics. 2004 Mar;113(3 Pt 1):e259-64.

PMID:
14993586
18.

Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients.

Lalor BC, Bhatnagar D, Winocour PH, Ishola M, Arrol S, Brading M, Durrington PN.

Diabet Med. 1990 Mar-Apr;7(3):242-5.

PMID:
2158410
19.

Comparison of the effects of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure.

Swain JF, Rouse IL, Curley CB, Sacks FM.

N Engl J Med. 1990 Jan 18;322(3):147-52.

20.
Items per page

Supplemental Content

Write to the Help Desk